ASX Share rice
Tue 18 May 2021 - 11:10:am (Sydney)

EOF Share Price

ECOFIBRE LIMITEDEOFPharmaceuticals, Biotechnology & Life Sciences

EOF Company Information

Name:

Ecofibre Limited

Sector:

Healthcare

Industry:

Drug Manufacturers-Specialty & Generic

Address:

680 George Street Sydney NSW Australia 2000

Phone:

61 7 3265 7630

CEO, MD & Director:

Mr. Eric Wang

CFO & Joint Company Sec.:

Mr. Jonathan Brown

VP of Global Operations:

Mr. Adam Cantwell

Chief Technology Officer:

Mr. Alastair Bor

Chief Science Officer:

Dr. Alex Capano

Gen. Counsel & Joint Company Sec.:

Ms. Robin Sheldon

Chief Operating Officer of Ananda Health:

Mr. Jerry Newton

Chief Strategy Officer:

Mr. John Ryan

Chief Revenue Officer:

Mr. Chuck Schneider

Chief Innovation Officer & Chief Sustainability Officer:

Mr. Mark Sunderland

Company Overview:

Ecofibre Limited, together with its subsidiaries, engages in breeding, growing, processing, and distributing hemp products in the United States and Australia. It offers protein powders, dehulled hemp seeds, and hemp seed oil products. The company also produces hemp nutraceutical products for human and pet consumption, as well as topical creams and salves; and develops hemp related fiber products. It sells its products through wholesalers and distributors, as well as pharmacy stores under the Ananda Food and Woolworths Macro brand names. The company was founded in 2009 and is based in Sydney, Australia.

EOF Share Price Information

Shares Issued:

341.02M

Market Capitalisation:

$219.96M

Revenue (TTM):

$36.36M

Revenue Per Share (TTM):

$0.12

Earnings per Share:

$0.002

Profit Margin:

0.0146

Operating Margin (TTM):

$-0.12

Return On Assets (TTM):

$-0.03

Return On Equity (TTM):

$0.01

Quarterly Revenue Growth (YOY):

-0.495

Gross Profit(TTM):

$38.10M

Diluted Earnings Per Share (TTM):

$0.002

QuarterlyEarnings Growth(YOY):

-0.053

EOF CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-22,528,000

Change To Liabilities:

$-477,000

Total Cashflow From Investing Activities:

$-22,528,000

Net Borrowings:

$9.40M

Net Income:

$13.16M

Total Cash From Operating Activities:

$5.81M

Depreciation:

$1.99M

Other Cashflow From Investing Activities:

$-126,000

Change To Inventory:

$-3,441,000

Change To Account Receivables:

$-6,837,000

Capital Expenditures:

$22.61M

EOF Income Statement

Income Date:

2020-06-30

Income Before Tax:

$17.25M

Net Income:

$13.16M

Gross Profit:

$38.46M

Operating Income:

$17.40M

Other Operating Expenses:

$1.92M

Interest Expense:

$-257,000

Income Tax Expense:

$4.10M

Total Revenue:

$50.72M

Cost Of Revenue:

$12.26M

EOF Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$659K

Total Liabilities:

$21.29M

Total Stockholder Equity:

$63M

Other Current Liabilities:

$8.69M

Total Assets:

$84.30M

Common Stock:

$62.38M

Other Current Assets:

$2.74M

Retained Earnings:

$-4,348,000

Other Assets:

$2.49M

Cash:

$18.25M

Total Current Liabilities:

$10.70M

Property - Plant & Equipment:

$35.68M

Net Tangible Assets:

$62.34M

Total Current Assets:

$45.46M

Long-Term Debt:

$10M

Net Receivables:

$9.62M

Short-Term Investments:

$38.83M

Inventory:

$10.01M

Accounts Payable:

$1.03M

Short-Term Investments:

$38.83

Non Current Liabilities Total:

$10.59M

EOF Share Price History

EOF News

17 May, 2021
Deutsche Bank today announced that the presentations from May 11 and 12 Depositary Receipts Virtual Investor Conference ("dbVIC") are now available for on-demand viewing. The event featured presentations from international companies with American Depositary Receipt (ADR) programs in the US.
07 May, 2021
Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Tuesday, May 11 and Wednesday, May 12, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.
24 Mar, 2021
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that...
20 Jan, 2021
The big shareholder groups in Ecofibre Limited ( ASX:EOF ) have power over the company. Generally speaking, as a...
06 Dec, 2020
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
22 Oct, 2020
The latest analyst coverage could presage a bad day for Ecofibre Limited (ASX:EOF), with the covering analyst making...
08 Sep, 2020
When close to half the companies in Australia have price-to-earnings ratios (or "P/E's") below 19x, you may consider...
07 Jul, 2020
Ecofibre Limited (Ecofibre, Company) (ASX:EOF, OTC-NASDAQ Intl Designation: EOFBF) is pleased to announce that the Lankenau Institute for Medical Research1 (LIMR) has begun patient enrollment in a Phase II clinical trial using Ananda Health hemp-derived CBD. The purpose of this study is to assess the efficacy of a hemp-based cannabidiol (CBD) product, Ananda Health Spectrum gelcaps, on the severity and duration of chemotherapy-induced peripheral neuropathy (CIPN) among breast, colon, and ovarian cancer patients who received common types of neurotoxic chemotherapy.